CN104203212A - 味道掩蔽的分散性片剂 - Google Patents
味道掩蔽的分散性片剂 Download PDFInfo
- Publication number
- CN104203212A CN104203212A CN201380016565.2A CN201380016565A CN104203212A CN 104203212 A CN104203212 A CN 104203212A CN 201380016565 A CN201380016565 A CN 201380016565A CN 104203212 A CN104203212 A CN 104203212A
- Authority
- CN
- China
- Prior art keywords
- tablet
- dispersibility
- exchange resin
- cation exchange
- taste masked
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN496DE2012 | 2012-02-21 | ||
IN496/DEL/2012 | 2012-02-21 | ||
PCT/IB2013/051432 WO2013124818A1 (en) | 2012-02-21 | 2013-02-21 | Taste masked dispersible tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104203212A true CN104203212A (zh) | 2014-12-10 |
Family
ID=54261187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380016565.2A Pending CN104203212A (zh) | 2012-02-21 | 2013-02-21 | 味道掩蔽的分散性片剂 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150031647A1 (he) |
EP (1) | EP2816997A1 (he) |
CN (1) | CN104203212A (he) |
AP (1) | AP2014007934A0 (he) |
AU (1) | AU2013223705A1 (he) |
CA (1) | CA2865312A1 (he) |
IN (1) | IN2014DN07895A (he) |
MX (1) | MX2014010038A (he) |
SG (1) | SG11201405053SA (he) |
WO (1) | WO2013124818A1 (he) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659792A (zh) * | 2014-05-08 | 2017-05-10 | 西梯茜生命工学股份有限公司 | 含氯丙咪嗪的遮味口服药物制剂 |
CN112353802A (zh) * | 2020-11-26 | 2021-02-12 | 山东诚创蓝海医药科技有限公司 | 一种富马酸伏诺拉生掩味组合物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020032245A1 (en) | 2000-07-27 | 2002-03-14 | Lyn Hughes | Resinate composition |
US20040067216A1 (en) | 2002-02-22 | 2004-04-08 | Karki Shyam B. | Hiv protease inhibitors supported on cation exchange resins for oral administration |
EP2198857A1 (en) * | 2008-12-19 | 2010-06-23 | Ratiopharm GmbH | Oral dispersible tablet |
US20130177520A1 (en) * | 2009-12-31 | 2013-07-11 | Ranbaxy Laboratories Limited | Taste masked dosage forms of bitter tasting anti-retroviral drugs |
-
2013
- 2013-02-21 AU AU2013223705A patent/AU2013223705A1/en not_active Abandoned
- 2013-02-21 IN IN7895DEN2014 patent/IN2014DN07895A/en unknown
- 2013-02-21 WO PCT/IB2013/051432 patent/WO2013124818A1/en active Application Filing
- 2013-02-21 CA CA2865312A patent/CA2865312A1/en not_active Abandoned
- 2013-02-21 SG SG11201405053SA patent/SG11201405053SA/en unknown
- 2013-02-21 AP AP2014007934A patent/AP2014007934A0/xx unknown
- 2013-02-21 CN CN201380016565.2A patent/CN104203212A/zh active Pending
- 2013-02-21 US US14/379,861 patent/US20150031647A1/en not_active Abandoned
- 2013-02-21 EP EP13719304.1A patent/EP2816997A1/en not_active Withdrawn
- 2013-02-21 MX MX2014010038A patent/MX2014010038A/es unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659792A (zh) * | 2014-05-08 | 2017-05-10 | 西梯茜生命工学股份有限公司 | 含氯丙咪嗪的遮味口服药物制剂 |
CN106659792B (zh) * | 2014-05-08 | 2020-04-28 | 西梯茜生命工学股份有限公司 | 含氯丙咪嗪的遮味口服药物制剂 |
CN112353802A (zh) * | 2020-11-26 | 2021-02-12 | 山东诚创蓝海医药科技有限公司 | 一种富马酸伏诺拉生掩味组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
AP2014007934A0 (en) | 2014-09-30 |
EP2816997A1 (en) | 2014-12-31 |
SG11201405053SA (en) | 2014-09-26 |
MX2014010038A (es) | 2014-12-05 |
IN2014DN07895A (he) | 2015-04-24 |
US20150031647A1 (en) | 2015-01-29 |
AU2013223705A1 (en) | 2014-09-11 |
WO2013124818A1 (en) | 2013-08-29 |
CA2865312A1 (en) | 2013-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6764959B2 (ja) | 医薬組成物 | |
AU2002222567B2 (en) | Composition improved in solubility or oral absorbability | |
CN109078006B (zh) | 一种帕布昔利布的药物制剂及其制备方法 | |
JP2002529392A (ja) | 改善された急速崩壊性錠剤 | |
WO2008018371A1 (fr) | Comprimé à désagrégation orale ayant un goût amer masqué et son procédé de production | |
CA2599649C (en) | Drug formulations having controlled bioavailability | |
TWI299994B (en) | Anti-allergic agent pharmaceutical composition and production method therefor | |
JP2007517864A (ja) | セフロキシムアキセチル顆粒及びこの製造方法 | |
EP2477609A1 (en) | Orally disintegrating pharmaceutical dosage form containing aripiprazole | |
CN104203212A (zh) | 味道掩蔽的分散性片剂 | |
CN106999600B (zh) | 包含粉碎乳糖或制粒乳糖的崩解性颗粒组合物 | |
HU194050B (en) | Process for loading of swelling, not poluable in water polimers with medroxi-progresteron acetat | |
CN104415097A (zh) | 荷叶或莲子心中总生物碱的舌下给药制剂及用途 | |
EP2698146B1 (en) | Tablet Formulations Comprising Tadalafil and Dapoxetine | |
WO2018191950A1 (en) | Palbociclib compositions and methods thereof | |
MX2010010383A (es) | Formulaciones orodispersables de inhibidores de fosfodiesterasa-5 (pde-5). | |
EP2572704A1 (en) | Orally-Disintegrating Formulations of Vildagliptin | |
EP3050575B1 (en) | Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition | |
CA2253769C (en) | Pharmaceutical compositions comprising fenofibrate | |
CN111000813B (zh) | 孟鲁司特钠咀嚼片及其制备方法 | |
JP2019514898A (ja) | アイバカフトールとルマカフトールの複合体製剤及びそれらの塩及び誘導体を含む医薬合剤組成物、それらの調製のための方法、並びにそれらを含有する医薬組成物 | |
JP7058104B2 (ja) | アプレピタントを有効成分とする医薬錠剤 | |
KR20160068975A (ko) | 약학 조성물 | |
CN102985077A (zh) | 固体形式 | |
JPWO2017209216A1 (ja) | 難溶性薬物の微粒子を含有する医薬組成物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |